Hydrus Microstent: A New Approach to Glaucoma Treatment
Summit Eye Center strives to provide the latest treatment options to our patients. Yesterday, Dr. Skelsey performed his first Hydrus Microstent procedures. In doing so, our patients are among the first in the Midwest to receive this innovative glaucoma treatment.
The Hydrus Microstent is the world’s first “intracanalicular scaffold” for the treatment of glaucoma. Roughly the size of an eyelash, it is made from a super-elastic, biocompatible alloy, which has been used in over 1 million implants in a variety of medical devices throughout the body.
In glaucoma patients, the pressure can rise inside the eye due to blockage of the eye’s fluid channels. The Hydrus Microstent is inserted into the primary fluid channel, Schlemm’s canal. It opens this channel to ensure that fluid can flow freely, which helps lower eye pressure.
This procedure is done at the same time as cataract surgery. The stent can be inserted through the same incisions that are used in cataract surgery. The healing from the procedure is similar to cataract surgery alone.